矽膠胃造瘻管市場（依管型、最終用戶、通路及管徑分類），全球預測（2026-2032年）

2025 年矽膠胃造瘻管市場價值為 1.4137 億美元，預計到 2026 年將成長至 1.5791 億美元，複合年成長率為 7.98%，到 2032 年將達到 2.4206 億美元。

關鍵市場統計數據
基準年 2025	1.4137億美元
預計年份：2026年	1.5791億美元
預測年份 2032	2.4206億美元
複合年成長率 (%)	7.98%

全面介紹矽膠胃造瘻管的臨床效用、材料優勢及其對多專診療路徑的影響

矽膠胃造瘻管在長期經腸營養和減壓治療中發揮核心作用，為需要持續胃部通路的患者提供了一種用途廣泛且生物相容性良好的選擇。這些裝置由柔軟、靈活的矽膠製成，與替代材料相比，其組織刺激性低且可長期留置，因此備受青睞。在臨床實踐中，裝置的選擇取決於解剖結構、患者的活動能力、預期治療持續時間和併發症風險，包括滲漏、移位和感染。

在胃造瘻器材生態系中，產品設計、臨床通訊協定、監管透明度和供應鏈韌性等方面都面臨亟待解決的轉型變革。

矽膠胃造瘻管領域正經歷著一場變革，其驅動力包括不斷發展的臨床實踐、以病人安全為中心的監管趨勢以及不斷變化的醫療服務模式。微創置入技術的日益普及以及門診和居家照護的興起，降低了病患對住院的依賴。這促使製造商重新設計設備，旨在簡化床邊置入和維護。因此，製造商優先考慮纖薄的設計和直覺的介面，以方便看護者和專業用戶使用。

分析2025年美國關稅改革對胃造瘻管供應鏈的採購、價格波動和籌資策略的影響

2025年的關稅政策調整重塑了在美國運作或與美國進行貿易的醫療設備相關人員的成本結構和採購環境。進口關稅的提高以及某些矽基醫療產品的重新分類，迫使採購部門重新評估供應商組成和總到岸成本。在某些情況下，現有採購合約已進行審查，條款也已重新談判，以納入關稅調整並反映更新後的跨境成本結構。

詳細的細分分析揭示了產品變體、護理環境、通路、插入技術和尺寸如何相互作用，從而影響臨床和商業策略。

細分市場分析揭示了產品屬性、臨床環境、通路、植入技術和器械尺寸如何共同影響臨床應用、採購決策和商業化策略。依產品類型，市場分為Low profile和標準型，Low profile又細分為球囊型和非球囊型，標準型也細分為球囊型和非球囊型。這種區分突出了不同的應用場景，例如Low profile器械優先考慮患者的舒適度和隱蔽性，而標準型器械則因其操作熟悉度和特定的解剖結構特徵而被選中。依最終用戶分類，市場分為三個細分市場：門診手術中心、居家醫療和醫院。這些最終用戶細分市場的手術量、護理通訊協定和庫存管理方法各不相同，從而影響產品組合和服務預期。

關鍵區域洞察：重點闡述全球各地醫療保健市場的法規結構、醫療服務模式演變和採購偏好差異

區域趨勢差異顯著，影響監管路徑、採購趨勢和設備設計重點。在美洲，相關人員關注的重點是基於價值的採購、價值鏈透明度和門診護理支持，從而推動了對支持快速康復和簡化居家護理的醫療設備的需求。在歐洲、中東和非洲地區，監管協調工作和不斷變化的報銷環境導致了截然不同的發展方向：一些市場優先考慮高階功能和上市後監測，而另一些市場則強調價格可負擔性和本地製造夥伴關係。

從公司層面深入洞察產品創新、臨床證據產生和分銷管道的穩健性如何決定醫療設備市場的競爭優勢

矽膠胃造瘻管市場的競爭格局取決於產品差異化、臨床證據、通路和可靠的生產製造。領先的製造商在產品的人體工學設計、球囊式產品的充氣和固定機制、增強生物相容性的材料加工技術以及簡化置入和術後護理的配套產品生態系統等方面展開競爭。與臨床中心建立策略夥伴關係以及對真實世界證據的重點投入是展現臨床性能和支持指南發布的關鍵差異化因素。

為製造商和醫療保健提供者提供具體、可操作的建議，以最佳化產品設計、供應鏈彈性、臨床證據和上市時間。

產業領導者應優先考慮一系列切實可行的舉措，以鞏固市場地位、改善臨床療效並增強商業性韌性。首先，應投資於迭代式產品設計改進，以降低植入複雜性並提高患者舒適度，尤其要專注於Low profile和標準平台，以及球囊和非球囊固定系統。這些以設計為中心的措施應與實用的臨床醫生培訓方案和標準化護理通訊協定相結合，以減少植入和術後護理的差異。

本文提供了一種透明的調查方法，描述了定性訪談、二手證據綜合、臨床檢驗以及用於得出可操作研究結果的細分框架。

本研究採用系統性的調查方法，結合質性資料和二手資料，以確保研究的嚴謹性、可重複性和相關性。主要資料來源包括對臨床醫生、採購負責人和設備工程師的訪談，以了解第一線人員對臨床需求、設備性能和採購限制的觀點。二手資料來源包括同行評審的臨床文獻、監管指導文件和製造商產品規格，檢驗驗證技術特性和安全考量。

簡明扼要的結論整合了臨床、商業性和供應鏈的優先事項，以指導策略決策，從而確保患者能夠持續獲得醫療服務。

總之，矽膠胃造瘻管在現代經腸營養護理中發揮著至關重要的作用，它兼具高度生物相容性材料和影響患者舒適度及看護者易用性的設計特徵。臨床實踐的改變，例如轉向門診護理、監管機構日益關注醫療設備安全以及供應鏈重組，共同為醫療設備製造商、臨床醫生和經銷商帶來了挑戰和機會。重要的是，按產品類型、最終用戶、通路、插入技術和導管尺寸進行細分，可以形成細微的價值點，並可針對這些價值點制定客製化的產品開發和商業化策略。

目錄

第1章：序言

第2章調查方法

• 研究設計
• 研究框架
• 市場規模預測
• 數據三角測量
• 調查結果
• 調查前提
• 調查限制

第3章執行摘要

• 首席體驗長觀點
• 市場規模和成長趨勢
• 2025年市佔率分析
• FPNV定位矩陣，2025
• 新的商機
• 下一代經營模式
• 產業藍圖

第4章 市場概覽

• 產業生態系與價值鏈分析
• 波特五力分析
• PESTEL 分析
• 市場展望
• 上市策略

第5章 市場洞察

• 消費者洞察與終端用戶觀點
• 消費者體驗基準
• 機會地圖
• 分銷通路分析
• 價格趨勢分析
• 監理合規和標準框架
• ESG與永續性分析
• 中斷和風險情景
• 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 矽膠胃造瘻管市場（依管型分類）

• 經皮視鏡胃造瘻術
• 放射插入法
• 手術植入

9. 依最終用戶分類的矽膠胃造瘻管市場

• 門診手術中心
• 居家醫療
• 醫院

第10章 矽膠胃造瘻管市場（依分銷管道分類）

• 線上
• 離線

第11章 矽膠胃造瘻管市場（依管徑分類）

• 12 Fr
• 14 Fr
• 16 Fr
• 18 Fr

12. 各地區矽膠胃造瘻管市場

• 美洲
  • 北美洲
  • 拉丁美洲
• 歐洲、中東和非洲
  • 歐洲
  • 中東
  • 非洲
• 亞太地區

第13章 矽膠胃造瘻管市場（依組別分類）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

14. 各國矽膠胃造瘻管市場

• 美國
• 加拿大
• 墨西哥
• 巴西
• 英國
• 德國
• 法國
• 俄羅斯
• 義大利
• 西班牙
• 中國
• 印度
• 日本
• 澳洲
• 韓國

第15章 美國矽膠胃造瘻管市場

第16章 中國矽膠胃造瘻管市場

第17章 競爭格局

• 市場集中度分析，2025年
  • 濃度比（CR）
  • 赫芬達爾-赫希曼指數 (HHI)
• 近期趨勢及影響分析，2025 年
• 2025年產品系列分析
• 基準分析，2025 年
• Abbott Laboratories
• ALCOR Scientific Inc
• Applied Medical Technology Inc
• Avanos Medical Inc
• B. Braun Melsungen AG
• Becton Dickinson and Company
• Beijing ZKSK Technology Co Ltd
• Cardinal Health Inc
• Coloplast A/S
• ConvaTec Group PLC
• Cook Medical LLC
• danumed Medizintechnik
• Degania Silicone Ltd
• Fresenius Kabi AG
• GBUK Enteral Ltd
• JMS Co Ltd
• Medicina Ltd
• Medline Industries Inc
• Moog Inc
• Poly Medicure Limited
• Smiths Group plc
• Teleflex Incorporated
• Vesco Medical LLC
• Vygon SA
• Well Lead Medical

The Silicone Gastrostomy Tube Market was valued at USD 141.37 million in 2025 and is projected to grow to USD 157.91 million in 2026, with a CAGR of 7.98%, reaching USD 242.06 million by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 141.37 million
Estimated Year [2026]	USD 157.91 million
Forecast Year [2032]	USD 242.06 million
CAGR (%)	7.98%

Comprehensive introduction that frames silicone gastrostomy tube clinical utility, material benefits, and implications for multidisciplinary care pathways

Silicone gastrostomy tubes play a central role in long-term enteral nutrition and decompression therapies, offering clinicians a versatile and biocompatible option for patients requiring sustained gastric access. Made from soft, flexible silicone, these devices are valued for their reduced tissue irritation and ability to remain in situ for extended durations compared with some alternative materials. In clinical practice, choice of device is informed by anatomical considerations, patient mobility, expected duration of therapy, and the risk profile for complications such as leakage, dislodgement, and infection.

Recent procedural refinements and a stronger focus on outpatient and home-based care have influenced device selection and post-procedure management. Interdisciplinary teams-including gastroenterologists, surgeons, nurses, and home health providers-increasingly coordinate around standardized insertion protocols and postoperative care pathways to improve patient comfort and reduce avoidable readmissions. Concurrently, manufacturers are refining device ergonomics and catheter interfaces to simplify insertion and maintenance, which enhances adoption across ambulatory surgical centers and home healthcare providers. Overall, the introductory landscape emphasizes patient-centered device choice, an evidence-informed approach to insertion technique, and a growing emphasis on device features that support outpatient care continuity and caregiver usability.

Urgent transformative shifts influencing product design, clinical protocols, regulatory transparency, and supply chain resilience across the gastrostomy device ecosystem

The landscape of silicone gastrostomy tubes is undergoing transformative shifts driven by clinical practice evolution, regulatory emphasis on patient safety, and changes in care delivery models. Minimally invasive insertion methods and a growing trend toward ambulatory and home-based management have reduced inpatient dependency, prompting device reengineering toward easier bedside insertion and simplified maintenance. As a result, manufacturers are prioritizing low-profile designs and intuitive interfaces that accommodate caregivers as well as professional users.

In parallel, the regulatory and reimbursement environment has elevated expectations for post-market surveillance and device traceability, motivating investment in quality assurance systems and supplier transparency. Clinicians are also adopting standardized care bundles that reduce infection risk and support longer dwell times for silicone devices, shifting the balance toward designs that minimize tissue trauma and leakage. Finally, supply chain resilience has become a strategic priority after recent disruptions, prompting stakeholders to diversify sources, validate alternative suppliers, and build inventory strategies that mitigate procurement risk while maintaining clinical continuity.

Analysis of how revised 2025 United States tariff measures influenced sourcing, pricing dynamics, and procurement strategies across the gastrostomy supply chain

Tariff policy changes in 2025 have introduced a recalibrated cost and sourcing landscape for medical device stakeholders operating within and trading with the United States. Higher import duties and altered classification of certain silicone-based medical products have encouraged purchasing teams to reassess supplier footprints and total landed costs. In some cases, legacy procurement contracts were re-evaluated to incorporate tariff contingencies and to renegotiate terms that reflect updated cross-border cost structures.

Consequently, manufacturers and distributors responded by exploring nearshoring opportunities, qualifying local manufacturing partners, and adjusting inventory strategies to preserve pricing competitiveness. Clinical providers felt the ripple effects in procurement cycles as purchasing committees balanced cost pressures with clinical performance requirements, often extending evaluation timelines to verify alternative suppliers could meet sterilization, sterility assurance, and regulatory compliance standards. Importantly, stakeholders focused on contractual flexibility and scenario planning to accommodate further policy shifts, while commercial teams recalibrated pricing strategies to preserve access to critical silicone gastrostomy products for patient care.

In-depth segmentation insights illustrating how product variants, care settings, channels, insertion techniques, and sizing interact to shape clinical and commercial strategies

Segmentation insights reveal how product attributes, care settings, distribution pathways, insertion techniques, and device sizing collectively influence clinical adoption, procurement decisions, and commercialization tactics. Based on product type the market is studied across Low Profile and Standard, with Low Profile further studied across Balloon and Non-Balloon and Standard further studied across Balloon and Non-Balloon; this distinction underscores divergent clinical use-cases where low-profile devices often prioritize patient comfort and concealability while standard systems are selected for procedural familiarity or specific anatomical considerations. Based on end user the market is studied across Ambulatory Surgical Centers, Home Healthcare, and Hospitals; these end-user segments reflect different procedural volumes, care protocols, and stocking practices that shape product mix and service expectations.

Based on distribution channel the market is studied across E-Commerce, Hospital Pharmacies, and Retail Pharmacies; channel selection affects purchasing cadence, accessibility for home caregivers, and the role of digital ordering platforms in replenishment. Based on tube type the market is studied across Percutaneous Endoscopic Gastrostomy, Radiologically Inserted, and Surgically Inserted; these clinical pathways influence device selection criteria, sterile field requirements, and clinician training needs. Finally, based on tube size the market is studied across 12 Fr, 14 Fr, 16 Fr, and 18 Fr; tube diameter choices reflect nutritional plans, flow requirements, and patient anatomy. Integrating these segmentation layers reveals that commercial strategies must be multidimensional-aligning product variants to specific clinical workflows, supporting differentiated training for insertion modalities, and tailoring distribution models to match end-user procurement behavior.

Key regional insights highlighting how regulatory frameworks, care delivery evolution, and procurement preferences diverge across global healthcare markets

Regional dynamics vary materially and carry implications for regulatory pathways, procurement preferences, and device design priorities. In the Americas stakeholder focus gravitates toward value-based procurement, supply chain visibility, and outpatient care enablement, prompting demand for devices that support fast recovery and simplified at-home maintenance. In the Europe, Middle East & Africa region regulatory harmonization initiatives and variable reimbursement landscapes drive a bifurcated approach: some markets prioritize premium features and post-market surveillance while others emphasize affordability and local manufacturing partnerships.

Across the Asia-Pacific region rapid infrastructure investment, expanding home healthcare services, and growing clinical expertise in minimally invasive procedures are accelerating adoption of silicone gastrostomy technologies. Each region presents distinct channel implications; for example, e-commerce penetration differs, hospital procurement practices vary, and the role of specialty distributors is shaped by local logistics and cold chain considerations. Consequently, manufacturers that adapt regulatory strategies, customize commercial messages to align with regional care paradigms, and invest in targeted clinical education will better navigate heterogeneous market conditions and support sustained product utilization across diverse healthcare systems.

Critical company-level insights showing how product innovation, clinical evidence generation, and distribution resilience determine competitive advantage in the device market

Competitive dynamics in the silicone gastrostomy tube space are defined by product differentiation, clinical evidence, distribution reach, and manufacturing reliability. Leading manufacturers compete on device ergonomics, inflation and retention mechanisms for balloon variants, material processing that enhances biocompatibility, and accessory ecosystems that simplify insertion and aftercare. Strategic partnerships with clinical centers and concerted investment in real-world evidence generation have become important differentiators because they demonstrate clinical performance and support guideline inclusion.

Distribution relationships also influence competitive positioning; firms that secure long-term contracts with hospital systems or that build resilient e-commerce and pharmacy pathways gain improved visibility and faster adoption cycles. Moreover, companies that maintain geographically diversified manufacturing footprints and robust quality systems reduce commercial disruption risk and better comply with evolving regulatory expectations. For new entrants, establishing credibility through targeted clinical studies, securing strong third-party sterilization and supply chain partners, and offering comprehensive clinician training programs are essential to gaining traction in an established competitive set.

Concrete, actionable recommendations for manufacturers and providers to optimize product design, supply chain resilience, clinical evidence, and go-to-market execution

Industry leaders should prioritize a set of actionable initiatives to strengthen market positioning, improve clinical outcomes, and fortify commercial resilience. First, invest in product design iterations that reduce insertion complexity and enhance patient comfort, with particular attention to both low-profile and standard platforms and to balloon versus non-balloon retention systems. Such design-focused work should be accompanied by pragmatic clinician training packages and standardized care protocols that reduce variability in insertion and aftercare.

Second, assess and reconfigure supply chain footprints to mitigate tariff exposure and sourcing risk by validating alternative suppliers, exploring nearshoring where feasible, and building inventory strategies that maintain clinical continuity. Third, accelerate real-world evidence programs that link device attributes to patient-centric outcomes, lower complication rates, and improved caregiver usability; this evidence will support payer conversations and hospital procurement committees. Fourth, tailor commercial strategies to end-user segmentation and distribution preferences by aligning product portfolios with ambulatory trends, enhancing e-commerce capabilities for caregiver access, and strengthening relationships with hospital pharmacies. Finally, cultivate regulatory and quality excellence by investing in post-market surveillance systems and traceability mechanisms that meet evolving regulatory expectations and bolster clinician confidence.

Transparent research methodology describing qualitative interviews, secondary evidence synthesis, clinical validation, and segmentation frameworks used to derive actionable insights

This research adheres to a structured methodology combining qualitative and secondary data sources to ensure rigor, reproducibility, and relevance. Primary inputs included interviews with practicing clinicians, procurement managers, and device engineers to capture first-hand perspectives on clinical needs, device performance, and procurement constraints. Secondary inputs comprised peer-reviewed clinical literature, regulatory guidance documents, and manufacturer product specifications to triangulate technical attributes and safety considerations.

Analysis prioritized cross-validation of claims through multiple evidence streams, including clinical expert validation sessions and supply chain audits to verify manufacturing and distribution robustness. Segmentation frameworks were informed by clinical workflows and procurement practices to ensure that product, end-user, channel, insertion technique, and sizing categories reflect real-world decision drivers. Finally, findings were synthesized into actionable insights through iterative review with clinical advisors and industry experts to enhance applicability for decision-makers in product development, procurement, and clinical operations.

Concise conclusion synthesizing clinical, commercial, and supply chain priorities to guide strategic decision-making for sustained patient access

In conclusion, silicone gastrostomy tubes occupy a pivotal role in modern enteral care, balancing material biocompatibility with design features that influence patient comfort and caregiver usability. The interplay of clinical practice shifts toward outpatient care, regulatory emphasis on device safety, and supply chain recalibration has created both challenges and opportunities for device manufacturers, clinicians, and distributors. Importantly, segmentation across product type, end user, distribution channel, insertion technique, and tube size creates nuanced value pockets that can be targeted with tailored product development and commercialization strategies.

Moving forward, stakeholders who integrate clinician-focused design improvements, robust real-world evidence generation, flexible sourcing strategies, and differentiated channel models will be best positioned to meet evolving care delivery demands. The collective objective should be to enhance patient outcomes while ensuring reliable access to appropriately specified silicone gastrostomy devices across care settings. With careful alignment of clinical priorities, manufacturing resilience, and targeted commercial execution, the ecosystem can sustainably deliver value to patients and healthcare systems alike.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Silicone Gastrostomy Tube Market, by Tube Type

• 8.1. Percutaneous Endoscopic Gastrostomy
• 8.2. Radiologically Inserted
• 8.3. Surgically Inserted

9. Silicone Gastrostomy Tube Market, by End User

• 9.1. Ambulatory Surgical Centers
• 9.2. Home Healthcare
• 9.3. Hospitals

10. Silicone Gastrostomy Tube Market, by Distribution Channel

• 10.1. Online
• 10.2. Offline

11. Silicone Gastrostomy Tube Market, by Tube Size

• 11.1. 12 Fr
• 11.2. 14 Fr
• 11.3. 16 Fr
• 11.4. 18 Fr

12. Silicone Gastrostomy Tube Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Silicone Gastrostomy Tube Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Silicone Gastrostomy Tube Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. United States Silicone Gastrostomy Tube Market

16. China Silicone Gastrostomy Tube Market

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025
• 17.5. Abbott Laboratories
• 17.6. ALCOR Scientific Inc
• 17.7. Applied Medical Technology Inc
• 17.8. Avanos Medical Inc
• 17.9. B. Braun Melsungen AG
• 17.10. Becton Dickinson and Company
• 17.11. Beijing ZKSK Technology Co Ltd
• 17.12. Cardinal Health Inc
• 17.13. Coloplast A/S
• 17.14. ConvaTec Group PLC
• 17.15. Cook Medical LLC
• 17.16. danumed Medizintechnik
• 17.17. Degania Silicone Ltd
• 17.18. Fresenius Kabi AG
• 17.19. GBUK Enteral Ltd
• 17.20. JMS Co Ltd
• 17.21. Medicina Ltd
• 17.22. Medline Industries Inc
• 17.23. Moog Inc
• 17.24. Poly Medicure Limited
• 17.25. Smiths Group plc
• 17.26. Teleflex Incorporated
• 17.27. Vesco Medical LLC
• 17.28. Vygon SA
• 17.29. Well Lead Medical

LIST OF FIGURES

• FIGURE 1. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL SILICONE GASTROSTOMY TUBE MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. UNITED STATES SILICONE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 12. CHINA SILICONE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC GASTROSTOMY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC GASTROSTOMY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC GASTROSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY RADIOLOGICALLY INSERTED, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY RADIOLOGICALLY INSERTED, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY RADIOLOGICALLY INSERTED, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY SURGICALLY INSERTED, BY REGION, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY SURGICALLY INSERTED, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY SURGICALLY INSERTED, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY 12 FR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY 12 FR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY 12 FR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY 14 FR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY 14 FR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY 14 FR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY 16 FR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY 16 FR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY 16 FR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY 18 FR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY 18 FR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY 18 FR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 43. AMERICAS SILICONE GASTROSTOMY TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 44. AMERICAS SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 45. AMERICAS SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 46. AMERICAS SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 47. AMERICAS SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 48. NORTH AMERICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 49. NORTH AMERICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 50. NORTH AMERICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 51. NORTH AMERICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 52. NORTH AMERICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 53. LATIN AMERICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 54. LATIN AMERICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 55. LATIN AMERICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 56. LATIN AMERICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 57. LATIN AMERICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 62. EUROPE, MIDDLE EAST & AFRICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 63. EUROPE SILICONE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 64. EUROPE SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 65. EUROPE SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 66. EUROPE SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 67. EUROPE SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 68. MIDDLE EAST SILICONE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 69. MIDDLE EAST SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 70. MIDDLE EAST SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 71. MIDDLE EAST SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 72. MIDDLE EAST SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 73. AFRICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 74. AFRICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 75. AFRICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 76. AFRICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 77. AFRICA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 78. ASIA-PACIFIC SILICONE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 79. ASIA-PACIFIC SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 80. ASIA-PACIFIC SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 81. ASIA-PACIFIC SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 82. ASIA-PACIFIC SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 83. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 84. ASEAN SILICONE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 85. ASEAN SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 86. ASEAN SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 87. ASEAN SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 88. ASEAN SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 89. GCC SILICONE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 90. GCC SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 91. GCC SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 92. GCC SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 93. GCC SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 94. EUROPEAN UNION SILICONE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 95. EUROPEAN UNION SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 96. EUROPEAN UNION SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 97. EUROPEAN UNION SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 98. EUROPEAN UNION SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 99. BRICS SILICONE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 100. BRICS SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 101. BRICS SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 102. BRICS SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 103. BRICS SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 104. G7 SILICONE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 105. G7 SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 106. G7 SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 107. G7 SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 108. G7 SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 109. NATO SILICONE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 110. NATO SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 111. NATO SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 112. NATO SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 113. NATO SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 114. GLOBAL SILICONE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 115. UNITED STATES SILICONE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 116. UNITED STATES SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 117. UNITED STATES SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 118. UNITED STATES SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 119. UNITED STATES SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)
• TABLE 120. CHINA SILICONE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 121. CHINA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE TYPE, 2018-2032 (USD MILLION)
• TABLE 122. CHINA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 123. CHINA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
• TABLE 124. CHINA SILICONE GASTROSTOMY TUBE MARKET SIZE, BY TUBE SIZE, 2018-2032 (USD MILLION)